Results 141 to 150 of about 5,546 (214)

Strong Additive Effect of Everolimus and Octreotide or Pasireotide on Meningioma Cells in Vitro: A New Therapeutic Strategy for These Tumors

, 2012
Anne Barlier, Thomas Graillon, Céline Defilles, Amira Mohamed, Alexandru Saveanu, Dominique Figarella‐Branger, Olivier Chinot, Pièrre-Hugues Roche, A Enjalbert, Henry Dufour   +9 more
openalex   +1 more source

Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study [PDF]

, 2013
Stephan Petersenn, Andrew J. Farrall, Christophe De Block, Шломо Мелмед, Jochen Schopohl, Philippe Caron, Ross C. Cuneo, David L. Kleinberg, Annamaria Colao, Matthieu Ruffin, Karina Hermosillo Reséndiz, Gareth Hughes, Ke Hu, Ariel Barkan   +13 more
openalex   +1 more source

Treatment with pasireotide LAR normalizes prolactin levels in patients with acromegaly and hyperprolactinemia: randomized, double-blind, 12-month, phase III study [PDF]

, 2013
Annamaria Colao, Pamela U. Freda, Feng Gu, Karina Hermosillo Reséndiz, Matthieu Ruffin, YinMiao Chen, Marcello D. Bronstein   +6 more
openalex   +1 more source

Somatostatin analogs in endothelial dysfunction. [PDF]

Am J Physiol Endocrinol Metab
Barabutis N.
europepmc   +1 more source

Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion [PDF]

, 2007
Maria Chiara Zatelli, Daniela Piccin, Cristina Vignali, Federico Tagliati, Maria Rosaria Ambrosio, Marta Bondanelli, Vincenzo Cimino, Antonio Bianchi, Herbert Schmid, M. Scanarini, Alfredo Pontecorvi, Laura De Marinis, Giulio Maira, Ettore C. degli Uberti   +13 more
openalex   +1 more source

Managing post-bariatric hypoglycemia: a systematic review of pharmacological therapies. [PDF]

Diabetol Metab Syndr
Sridharan K, Sivaramakrishnan G.
europepmc   +1 more source

Cushing’s disease: is pasireotide LAR a breakthrough in adjuvant therapy after unsuccessful surgery?

, 2017
Przemysław Witek, Marta Mazur, Joanna Witek   +2 more
openalex   +1 more source

Phase II Trial of Pasireotide to Prevent GI Toxicity and Acute Gvhd in Allogeneic HSCT

, 2020
Sendhilnathan Ramalingam, Sharareh Siamakpour‐Reihani, Lauren Bohannon, Yi Ren, Alexander B. Sibley, Andrew B. Nixon, Jing Lyu, Jichun Xie, Taewoong Choi, Cristina Gasparetto, Mitchell E. Horwitz, Gwynn D. Long, Richard D. Lopez, David A. Rizzieri, Stefanie Sarantopoulos, Nelson J. Chao, Anthony D. Sung   +16 more
openalex   +1 more source

Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells

, 2021
Laura Streit, Sophie Moog, Sylvain Hugel, Marion Rame, Émeline Tanguy, Virginie Andry, Herbert Schmid, Laurent Brunaud, Florence Bihain, Claire Nominé-Criqui, Yannick Goumon, Stéphanie Lacomme, Sandra Lomazzi, Michel Vix, Didier Mutter, Nicolas Vitale, Stéphane Ory, Stéphane Gasman   +17 more
openalex   +2 more sources

The influence of somatostatin analogues on the incidence of pancreatic fistulas and postoperative morbidity in patients undergoing pancreatic resection: A Bayesian network meta-analysis. [PDF]

PLoS One
Hou Z, Hou S, Wang Z, Wang H, Deng M, Fan H.   +5 more
europepmc   +1 more source